Register entry

Aadi Bioscience, Inc.

Data as of · How to read this entry

Registered sites
0
Active NDC listings
1
Live patents
7
Exclusivities
1
Countries
0
Exclusivity

Patents and exclusivities

7
PatentProductCoversExpiry
8911786FYARROsirolimusproductFeb 2029
10206887FYARROsirolimusproductApr 2030
10705070FYARROsirolimusproductMar 2036
12061183FYARROsirolimusproductMar 2036
10973806FYARROsirolimususeJun 2036
12133844FYARROsirolimususeJun 2036
11497737FYARROsirolimusproductOct 2040
ProductExclusivityUntil
FYARROSIROLIMUSODE-386 Orphan drugNov 2028
Catalogue

Marketed products

1
BrandGeneric nameForm / routeNDC
FYARROSirolimusinjection, powder, lyophilized, for suspension, intravenous80803-153NDA
Compare

Other companies listing sirolimus

Enquiry

Common questions

Is Aadi Bioscience, Inc. FDA approved?
Aadi Bioscience, Inc. holds no registered establishment of its own; 1 drug product is listed under its name in the National Drug Code Directory, made at sites registered to other firms.
What drugs does Aadi Bioscience, Inc. make?
1 product is listed under Aadi Bioscience, Inc. in the openFDA NDC Directory, most often as injection, powder, lyophilized, for suspension. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.